Author:
Hirakawa Akihiro,Matsui Shigeyuki
Publisher
The Biometric Society of Japan
Reference27 articles.
1. Amemiya, T. (1980). The n -2-order mean squared errors of the maximum likelihood and the minimum logit chi-square estimator. The Annals of Statistics 8, 488-505.
2. Bekele, B. N. and Shen, Y. (2005). A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial. Biometrics 61, 344-354.
3. Braun, T. M. (2002). The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes. Controlled Clinical Trials 23, 240-256.
4. Braun, T. M. and Wang, S. (2010). A hierarchical Bayesian design for phase I trials of novel combinations of cancer therapeutic agents. Biometrics 66, 805-812. Cheung, Y. K. (2011). Dose-finding by the continual reassessment method. New York: Chapman and Hall/CRC Press.
5. Conaway, M. R., Dunbar, S., and Peddada, S. D. (2004). Designs for single- or multiple-agent phase I trials. Biometrics 60, 661-669.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献